Pandite Arundathy N. 4

What Happened

• Pandite Arundathy, Chief Medical Officer of Shattuck Labs (STTK), sold 30,000 shares on June 30, 2026. The reported weighted-average price was $7.01 per share, for gross proceeds of approximately $210,300. The Form 4 lists the transaction as an open-market or private sale (code S).

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely).
• Price: weighted average $7.01; individual trades ranged from $6.62 to $7.40 (footnote).
• Shares sold: 30,000; gross proceeds ≈ $210,300.
• Footnote F1: Sale executed pursuant to a Rule 10b5-1 trading plan adopted February 2, 2026.
• Footnote F2: Weighted average price reported; the filer can provide the number of shares sold at each price on request.
• Shares owned after transaction: not specified in the provided excerpt of the filing.

Context

• This was a sale (disposition) executed under a pre-established 10b5-1 plan, which is commonly used to schedule sales in advance and is generally considered routine; the filing itself does not state the seller’s motivation.